Literature DB >> 3884583

Effect of lung inflation on lung blood volume and pulmonary venous flow.

R Brower, R A Wise, C Hassapoyannes, B Bromberger-Barnea, S Permutt.   

Abstract

Phasic changes in lung blood volume (LBV) during the respiratory cycle may play an important role in the genesis of the respiratory wave in arterial pressure, or pulsus paradoxus. To better understand the effects of lung inflation on LBV, we studied the effect of changes in transpulmonary pressure (delta Ptp) on pulmonary venous flow (Qv) in eight isolated canine lungs with constant inflow. Inflation when the zone 2 condition was predominant resulted in transient decreases in Qv associated with increases in LBV. In contrast, inflation when the zone 3 condition was predominant resulted in transient increases in Qv associated with decreases in LBV. These findings are consistent with a model of the pulmonary vasculature that consists of alveolar and extra-alveolar vessels. Blood may be expelled from alveolar vessels but is retained in extra-alveolar vessels with each inflation. The net effect on LBV and thus on Qv is dependent on the zone conditions that predominate during inflation, with alveolar or extra-alveolar effects being greater when the zone 3 or zone 2 conditions predominate, respectively. Lung inflation may therefore result in either transiently augmented or diminished Qv. Phasic changes in left ventricular preload may therefore depend on the zone conditions of the lungs during the respiratory cycle. This may be an important modulator of respiratory variations in cardiac output and blood pressure.

Entities:  

Mesh:

Year:  1985        PMID: 3884583     DOI: 10.1152/jappl.1985.58.3.954

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  24 in total

Review 1.  Fluid responsiveness in mechanically ventilated patients: a review of indices used in intensive care.

Authors:  Karim Bendjelid; Jacques-A Romand
Journal:  Intensive Care Med       Date:  2003-01-21       Impact factor: 17.440

2.  Lung heparan sulfates modulate K(fc) during increased vascular pressure: evidence for glycocalyx-mediated mechanotransduction.

Authors:  Randal O Dull; Mark Cluff; Joseph Kingston; Denzil Hill; Haiyan Chen; Soeren Hoehne; Daniel T Malleske; Rajwinederjit Kaur
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-09       Impact factor: 5.464

3.  Mechanisms behind inter-individual differences in lung diffusing capacity.

Authors:  G Miserocchi; G Messinesi; F Tana; E Passoni; S Adamo; R Romano; E Beretta
Journal:  Eur J Appl Physiol       Date:  2007-12-04       Impact factor: 3.078

Review 4.  Interactions between respiration and systemic hemodynamics. Part II: practical implications in critical care.

Authors:  François Feihl; Alain F Broccard
Journal:  Intensive Care Med       Date:  2008-09-30       Impact factor: 17.440

Review 5.  Interactions between respiration and systemic hemodynamics. Part I: basic concepts.

Authors:  François Feihl; Alain F Broccard
Journal:  Intensive Care Med       Date:  2008-09-30       Impact factor: 17.440

Review 6.  Perioperative implications of pericardial effusions and cardiac tamponade.

Authors:  P R Madhivathanan; C Corredor; A Smith
Journal:  BJA Educ       Date:  2020-06-12

Review 7.  Determinants of systemic venous return and the impact of positive pressure ventilation.

Authors:  David Berger; Jukka Takala
Journal:  Ann Transl Med       Date:  2018-09

Review 8.  Cardiopulmonary interactions and volume status assessment.

Authors:  Alain F Broccard
Journal:  J Clin Monit Comput       Date:  2012-08-30       Impact factor: 2.502

9.  Mechanics of the circulation during cardiopulmonary resuscitation. Pathophysiology and techniques (Part II).

Authors:  J Peters; P Ihle
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

10.  Variations in pulmonary artery occlusion pressure to estimate changes in pleural pressure.

Authors:  Patrick Bellemare; Peter Goldberg; Sheldon A Magder
Journal:  Intensive Care Med       Date:  2007-08-31       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.